SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001181431-12-056079
Filing Date
2012-11-01
Accepted
2012-11-01 16:38:29
Documents
2
Period of Report
2012-10-31
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 DYNAVAX TO INITIATE PHASE 1 STUDY FOR ASTHMA rrd359146.htm 8-K 12727
2 DYNAVAX TO INITIATE PHASE 1 STUDIES FOR TLR-9 AGONIST FOR ASTHMA rrd359146_38667.htm EX-99 6118
  Complete submission text file 0001181431-12-056079.txt   19947
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34207 | Film No.: 121174018
SIC: 2834 Pharmaceutical Preparations